Sobril is a brief-performing benzodiazepine. It boosts neuronal membrane permeability to Cl ions by binding to stereospecific benzodiazepine receptors on the postsynaptic GABA neuron w/during the CNS (such as the limbic method, reticular development) and maximizing the GABA inhibitory effects leading to hyperpolarisation and stabilisation. Signs

Article Under Review